Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K A Foon

Showing results (111-120 of 184) with videos related to

Pageof 19
Sort By:
The Journal of Clinical Investigation|July 1, 1995
Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccineK A Foon, M Chakraborty, W J John, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Anti-idiotype antibodies as potential therapeutic agents for human breast cancerM Bhattacharya-Chatterjee, E Mrozek, S Mukerjee, et al.
Cancer Research|October 1, 1984
Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigenK M Hwang, K A Foon, P H Cheung, et al.
Cancer Research|February 1, 1985
Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapyR W Schroff, K A Foon, S M Beatty, et al.
Leukemia|December 1, 1992
Clinical significance of monoclonal proteins in chronic lymphocytic leukemiaZ P Bernstein, J E Fitzpatrick, A O'Donnell, et al.
Cancer Gene Therapy|December 29, 2000
Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2H E Zeytin, P K Tripathi, M Bhattacharya-Chatterjee, et al.
Anticancer Research|November 1, 1992
The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activityH Watanabe, K Narumi, C C Stewart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Determination of the optimal human cell lines for development of human hybridomasP G Abrams, J A Knost, G Clarke, et al.
Gynecologic Oncology|November 1, 1990
Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assayJ Fanning, W C Biddle, M Goldrosen, et al.
American Journal of Hematology|January 1, 1981
An antigen expressed by cells of the myelo-monocytic lineageK A Foon, R J Billing, J H Fitchen, et al.
Pageof 19

Showing results (111-120 of 184) with videos related to

Sort By:
Pageof 19
The Journal of Clinical Investigation|July 1, 1995
Immune response to the carcinoembryonic antigen in patients treated with an anti-idiotype antibody vaccineK A Foon, M Chakraborty, W J John, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Anti-idiotype antibodies as potential therapeutic agents for human breast cancerM Bhattacharya-Chatterjee, E Mrozek, S Mukerjee, et al.
Cancer Research|October 1, 1984
Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigenK M Hwang, K A Foon, P H Cheung, et al.
Cancer Research|February 1, 1985
Human anti-murine immunoglobulin responses in patients receiving monoclonal antibody therapyR W Schroff, K A Foon, S M Beatty, et al.
Leukemia|December 1, 1992
Clinical significance of monoclonal proteins in chronic lymphocytic leukemiaZ P Bernstein, J E Fitzpatrick, A O'Donnell, et al.
Cancer Gene Therapy|December 29, 2000
Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2H E Zeytin, P K Tripathi, M Bhattacharya-Chatterjee, et al.
Anticancer Research|November 1, 1992
The effect of anti-CD3 on the induction of non-MHC restricted cytolytic activityH Watanabe, K Narumi, C C Stewart, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1983
Determination of the optimal human cell lines for development of human hybridomasP G Abrams, J A Knost, G Clarke, et al.
Gynecologic Oncology|November 1, 1990
Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assayJ Fanning, W C Biddle, M Goldrosen, et al.
American Journal of Hematology|January 1, 1981
An antigen expressed by cells of the myelo-monocytic lineageK A Foon, R J Billing, J H Fitchen, et al.
Pageof 19